TEZSPIRE – Newest FDA-Approved Biologic for Severe Asthma
Returning guest, Dr. Neal Jain discusses asthma, severe asthma, and AstraZeneca and Amgen’s Tezspire™ (tezepelumab-ekko), the newest FDA-approved biologic for severe asthma. He is joined by a patient that shares their experience with severe asthma.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Asthma. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Asthma and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Asthma?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Neal Jain discusses asthma, severe asthma, and AstraZeneca and Amgen’s Tezspire™ (tezepelumab-ekko), the newest FDA-approved biologic for severe asthma.
- Key Point: He is joined by a patient that shares their experience with severe asthma. Dr.
- Key Point: Neal Jain obtained his medical degree from the Medical College of Wisconsin.
- Key Point: Trained in Pediatrics at the Phoenix Children’s Hospital, he served there as chief resident from 2001 to 2002.
- Key Point: He has trained in Allergy, Asthma, and immunology at the National Jewish Health Center where he was appointed Chief Fellow, and University of Colorado School of Medicine in Denver.
Dr. Neal Jain obtained his medical degree from the Medical College of Wisconsin. Trained in Pediatrics at the Phoenix Children’s Hospital, he served there as chief resident from 2001 to 2002. He has trained in Allergy, Asthma, and immunology at the National Jewish Health Center where he was appointed Chief Fellow, and University of Colorado School of Medicine in Denver. Dr. Jain has been an active member of the community, proudly serving as President of the Arizona Allergy Society and a fellow of the American Academy of Allergy, Asthma, & Immunology and Pediatrics.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



